N.M. Stat. Ann. § 26-1-2 – New Mexico

Status: Enacted
Link: http://public.nmcompcomm.us/nmpublic/gateway.dll/?f=templates&fn=default.htm

Amends the New Mexico Drug, Device and Cosmetic Act to allow pharmacists to substitute biosimilar and interchangeable biosimilar biologic products for another biologic product that has been prescribed by a physician.

Return to Database Search

© 2018-2019 The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found

Leave A Comment